465 related articles for article (PubMed ID: 19586764)
21. The course of fever following influenza virus infection in children treated with oseltamivir.
Suzuki E; Ichihara K
J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
[TBL] [Abstract][Full Text] [Related]
22. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
[TBL] [Abstract][Full Text] [Related]
23. Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.
Ciblak MA; Hasoksuz M; Escuret V; Valette M; Gul F; Yilmaz H; Turan N; Bozkaya E; Badur S
J Med Virol; 2009 Sep; 81(9):1645-51. PubMed ID: 19626608
[TBL] [Abstract][Full Text] [Related]
24. Antiviral effect of catechins in green tea on influenza virus.
Song JM; Lee KH; Seong BL
Antiviral Res; 2005 Nov; 68(2):66-74. PubMed ID: 16137775
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
26. Oligonol a low molecular weight polyphenol of lychee fruit extract inhibits proliferation of influenza virus by blocking reactive oxygen species-dependent ERK phosphorylation.
Gangehei L; Ali M; Zhang W; Chen Z; Wakame K; Haidari M
Phytomedicine; 2010 Nov; 17(13):1047-56. PubMed ID: 20554190
[TBL] [Abstract][Full Text] [Related]
27. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo.
Yang Y; Xiu J; Zhang L; Qin C; Liu J
Phytomedicine; 2012 Dec; 20(1):67-70. PubMed ID: 23146421
[TBL] [Abstract][Full Text] [Related]
28. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
29. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
30. Antiviral effect of Sanicula europaea L. leaves extract on influenza virus-infected cells.
Turan K; Nagata K; Kuru A
Biochem Biophys Res Commun; 1996 Aug; 225(1):22-6. PubMed ID: 8769089
[TBL] [Abstract][Full Text] [Related]
31. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication.
Choi HJ; Song JH; Park KS; Kwon DH
Eur J Pharm Sci; 2009 Jun; 37(3-4):329-33. PubMed ID: 19491023
[TBL] [Abstract][Full Text] [Related]
33. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
[TBL] [Abstract][Full Text] [Related]
34. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
[TBL] [Abstract][Full Text] [Related]
35. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice.
Seeram NP; Adams LS; Henning SM; Niu Y; Zhang Y; Nair MG; Heber D
J Nutr Biochem; 2005 Jun; 16(6):360-7. PubMed ID: 15936648
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.
Liu Z; Guo Z; Wang G; Zhang D; He H; Li G; Liu Y; Higgins D; Walsh A; Shanahan-Prendergast L; Lu J
Eur J Pharm Sci; 2009 Oct; 38(3):215-23. PubMed ID: 19616097
[TBL] [Abstract][Full Text] [Related]
37. Update: influenza activity - United States, September 28, 2008--January 31, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(5):115-9. PubMed ID: 19214161
[TBL] [Abstract][Full Text] [Related]
38. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
39. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
Duwe S; Schweiger B
J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]